Company intelligence / Profile preview
Parabon NanoLabs
Reston, Virginia, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
The company is developing oncology therapeutics, synthetic vaccines, and diagnostic tools using DNA nanotechnology. No commercial biomedical products have been launched yet, though multiple therapeutics are in development.
- Therapeutic areas
- OncologyInfectious DiseasesNeurology
- Modalities
- DNA nanostructureDNA vaccineNanopharmaceutical
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Edgewood Chemical Biological CenterUnited States Army Research OfficeNational Science Foundation
Beyond the preview
Go deeper on Parabon NanoLabs.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Parabon NanoLabs.